Literature DB >> 7478554

HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype.

P D Salvati1, P R Ranford, J Ford, U R Kees.   

Abstract

Based on cytogenetic analysis, chromosomal translocations involving band 10q24 occur in 4-7% of T-cell acute lymphoblastic leukemia (T-ALL). The HOX11 gene is located in this chromosomal band and is activated by translocations t(10;14) (q24;q11) and t(7;10) (q35;q24). Ectopic expression of the HOX11 gene appears to be involved in the development of T-cell tumors. The aim of this study was to determine the frequency of HOX11 activation in pediatric ALL patients and to correlate gene expression with ALL immunophenotype. None of 53 B-lineage ALLs was positive for HOX11 expression, however, Northern blot and RT-PCR analysis revealed that four of 12 T-ALLs (33%) showed expression of the gene. In order to assess whether HOX11 expression is present in other pediatric malignancies we examined a panel of 20 tumor cell lines established from solid tumors and leukemias, but none of them showed expression of HOX11. Using our RT-PCR method we confirmed that HOX11 expression is not detectable in normal T-cells. These findings indicate that HOX11 expression in pediatric ALL is exclusive to T-ALL and does not occur in B-lineage ALL. The frequency detected by molecular techniques was significantly higher than the frequency reported in the literature based on cytogenetic analysis. These results support the notion that ectopic expression of the HOX11 homeobox gene is a crucial step in T-cell tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478554

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Cooperative DNA-binding and sequence-recognition mechanism of aristaless and clawless.

Authors:  Ken-ichi Miyazono; Yuehua Zhi; Yuriko Takamura; Koji Nagata; Kaoru Saigo; Tetsuya Kojima; Masaru Tanokura
Journal:  EMBO J       Date:  2010-04-13       Impact factor: 11.598

2.  TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.

Authors:  Bronwyn M Owens; Teresa S Hawley; Lisa M Spain; Kristi A Kerkel; Robert G Hawley
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

3.  Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study.

Authors:  Amanda L Cleaver; Alex H Beesley; Martin J Firth; Nina C Sturges; Rebecca A O'Leary; Stephen P Hunger; David L Baker; Ursula R Kees
Journal:  Mol Cancer       Date:  2010-05-12       Impact factor: 27.401

4.  A model for spontaneous B-lineage lymphomas in IgHmu-HOX11 transgenic mice.

Authors:  M R Hough; M D Reis; R Singaraja; D M Bryce; S Kamel-Reid; I Dardick; M L Breitman; I D Dubé
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

5.  Refined physical map of the human PAX2/HOX11/NFKB2 cancer gene region at 10q24 and relocalization of the HPV6AI1 viral integration site to 14q13.3-q21.1.

Authors:  Sheryl M Gough; Margaret McDonald; Xiao-Ning Chen; Julie R Korenberg; Antonino Neri; Tomas Kahn; Michael R Eccles; Christine M Morris
Journal:  BMC Genomics       Date:  2003-03-03       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.